View in EDS HTML Full Text PDF Full Text

Lumicitabine, an orally administered nucleoside analog, in infants hospitalized with respiratory syncytial virus (RSV) infection: Safety, efficacy, and pharmacokinetic results.

Saved in:
Bibliographic Details
Title: Lumicitabine, an orally administered nucleoside analog, in infants hospitalized with respiratory syncytial virus (RSV) infection: Safety, efficacy, and pharmacokinetic results.
Authors: Oey A; Janssen Research & Development, LLC, South San Francisco, California, United States of America., McClure M; Janssen Research & Development, LLC, South San Francisco, California, United States of America., Symons JA; Janssen Research & Development, LLC, South San Francisco, California, United States of America., Chanda S; Janssen Research & Development, LLC, South San Francisco, California, United States of America., Fry J; Janssen Research & Development, LLC, South San Francisco, California, United States of America., Smith PF; Certara Strategic Consulting, Parsippany, New Jersey, United States of America., Luciani K; Department of Infectious Diseases Hospital de Especialidades Pediátricas Omar Torrijos Herrera, Panama City, Panama., Fayon M; CHU de Bordeaux, Pneumologie pédiatrique, CIC 1401 (INSERM), Hôpital Pellegrin-Enfants, Bordeaux Cedex, France., Chokephaibulkit K; Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand., Uppala R; Department of Pediatrics, Khon Kaen University, Khon Kaen, Thailand., Bernatoniene J; Paediatric Infectious Disease and Immunology Department, Bristol Royal Hospital for Children, Bristol, United Kingdom., Furuno K; General Pediatrics & Interdisciplinary Medicine Fukuoka Children's Hospital, Fukuoka, Japan., Stanley T; Department of Paediatrics, University of Otago, Wellington, New Zealand., Huntjens D; Janssen Research & Development, Beerse, Belgium., Witek J; Janssen Research & Development, LLC, Titusville, New Jersey, United States of America.
Corporate Authors: 503 and RSV2004 Study Groups
Source: PloS one [PLoS One] 2023 Jul 19; Vol. 18 (7), pp. e0288271. Date of Electronic Publication: 2023 Jul 19 (Print Publication: 2023).
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37467213
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Lumicitabine, an orally administered nucleoside analog, in infants hospitalized with respiratory syncytial virus (RSV) infection: Safety, efficacy, and pharmacokinetic results.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Oey+A%22">Oey A</searchLink>; Janssen Research & Development, LLC, South San Francisco, California, United States of America.<br /><searchLink fieldCode="AU" term="%22McClure+M%22">McClure M</searchLink>; Janssen Research & Development, LLC, South San Francisco, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Symons+JA%22">Symons JA</searchLink>; Janssen Research & Development, LLC, South San Francisco, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Chanda+S%22">Chanda S</searchLink>; Janssen Research & Development, LLC, South San Francisco, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Fry+J%22">Fry J</searchLink>; Janssen Research & Development, LLC, South San Francisco, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Smith+PF%22">Smith PF</searchLink>; Certara Strategic Consulting, Parsippany, New Jersey, United States of America.<br /><searchLink fieldCode="AU" term="%22Luciani+K%22">Luciani K</searchLink>; Department of Infectious Diseases Hospital de Especialidades Pediátricas Omar Torrijos Herrera, Panama City, Panama.<br /><searchLink fieldCode="AU" term="%22Fayon+M%22">Fayon M</searchLink>; CHU de Bordeaux, Pneumologie pédiatrique, CIC 1401 (INSERM), Hôpital Pellegrin-Enfants, Bordeaux Cedex, France.<br /><searchLink fieldCode="AU" term="%22Chokephaibulkit+K%22">Chokephaibulkit K</searchLink>; Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.<br /><searchLink fieldCode="AU" term="%22Uppala+R%22">Uppala R</searchLink>; Department of Pediatrics, Khon Kaen University, Khon Kaen, Thailand.<br /><searchLink fieldCode="AU" term="%22Bernatoniene+J%22">Bernatoniene J</searchLink>; Paediatric Infectious Disease and Immunology Department, Bristol Royal Hospital for Children, Bristol, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Furuno+K%22">Furuno K</searchLink>; General Pediatrics & Interdisciplinary Medicine Fukuoka Children's Hospital, Fukuoka, Japan.<br /><searchLink fieldCode="AU" term="%22Stanley+T%22">Stanley T</searchLink>; Department of Paediatrics, University of Otago, Wellington, New Zealand.<br /><searchLink fieldCode="AU" term="%22Huntjens+D%22">Huntjens D</searchLink>; Janssen Research & Development, Beerse, Belgium.<br /><searchLink fieldCode="AU" term="%22Witek+J%22">Witek J</searchLink>; Janssen Research & Development, LLC, Titusville, New Jersey, United States of America.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22503+and+RSV2004+Study+Groups%22">503 and RSV2004 Study Groups</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101285081%22">PloS one</searchLink> [PLoS One] 2023 Jul 19; Vol. 18 (7), pp. e0288271. <i>Date of Electronic Publication: </i>2023 Jul 19 (<i>Print Publication: </i>2023).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101285081 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1932-6203 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219326203%22">19326203 </searchLink><i>NLM ISO Abbreviation: </i>PLoS One <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37467213
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1371/journal.pone.0288271
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e0288271
    Titles:
      – TitleFull: Lumicitabine, an orally administered nucleoside analog, in infants hospitalized with respiratory syncytial virus (RSV) infection: Safety, efficacy, and pharmacokinetic results.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Oey A
      – PersonEntity:
          Name:
            NameFull: McClure M
      – PersonEntity:
          Name:
            NameFull: Symons JA
      – PersonEntity:
          Name:
            NameFull: Chanda S
      – PersonEntity:
          Name:
            NameFull: Fry J
      – PersonEntity:
          Name:
            NameFull: Smith PF
      – PersonEntity:
          Name:
            NameFull: Luciani K
      – PersonEntity:
          Name:
            NameFull: Fayon M
      – PersonEntity:
          Name:
            NameFull: Chokephaibulkit K
      – PersonEntity:
          Name:
            NameFull: Uppala R
      – PersonEntity:
          Name:
            NameFull: Bernatoniene J
      – PersonEntity:
          Name:
            NameFull: Furuno K
      – PersonEntity:
          Name:
            NameFull: Stanley T
      – PersonEntity:
          Name:
            NameFull: Huntjens D
      – PersonEntity:
          Name:
            NameFull: Witek J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 19
              M: 07
              Text: 2023 Jul 19
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1932-6203
          Numbering:
            – Type: volume
              Value: 18
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: PloS one
              Type: main
ResultId 1